Pfizer said on Tuesday the next few years will be bumpy, beginning with 2026, due to lower sales of its COVID vaccine and ...
Pfizer expects adjusted per-share earnings of $2.80 to $3 next year, below analysts’ consensus estimate of $3.06, according to FactSet. Revenue is expected to total $59.5 billion to $62.5 billion, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback